SPSenores Pharmaceuticals544319Leadership appointment or

Board re-appoints Managing Director and Whole-time Director for three years each

Board approved re-appointment of Mr. Swapnil Jatinbhai Shah as Managing Director (3 years from October 15, 2026) and Mr. Chetan Bipinchandra Shah as Whole-time Director (3 years from November 10, 2026).

By ScoutQuest · Tue 13 Oct 2026, 12:23 PM IST · 2 min read

MD re-appointment term

3 years from October 15, 2026

Whole-time Director re-appointment term

3 years from November 10, 2026

Board meeting date

October 13, 2026

What the Board approved

• Mr. Swapnil Jatinbhai Shah re-appointed as the Managing Director of the Company for a further period of three (3) consecutive years with effect from October 15, 2026.
• Mr. Chetan Bipinchandra Shah re-appointed as the Whole-time Director of the Company for a further period of three (3) consecutive years with effect from November 10, 2026.
• Both are liable to retire by rotation, and both re-appointments are subject to the approval of shareholders, to be obtained through a postal ballot process.

The Board took this decision at its meeting held on October 13, 2026, based on the recommendation of the Nomination and Remuneration Committee.

Who is being re-appointed

• Mr. Swapnil Jatinbhai Shah is the Promoter and Managing Director of the Company. He has over 15 years of experience in the pharmaceutical sector and was previously involved in business operations in a Delaware based pharmaceutical company. He is currently leading the Company's overall functioning and is part of the core management team, responsible for product portfolio management, corporate strategy, business development and overall strategic management. He holds a master's degree in business administration from Hofstra University, New York and a bachelor's degree in chemical engineering from Nirma University. He is a convenor of the pharma panel in the Confederation of Indian Industry (CII), Gujarat State Council.
• Mr. Chetan Bipinchandra Shah is the Whole-Time Director and Chief Operating Officer of the Company. He has over 30 years of experience, of which 25 years is in the pharmaceutical industry. He is part of the core management team and is responsible for strategy planning, capital expenditure planning, capacity expansion, policy enforcement, mergers and acquisitions, supply chain for both domestic and international markets, manufacturing processes and automation, risk management and overall management information system.

Other disclosures in the update

• Mr. Swapnil Jatinbhai Shah is not related inter-se to any other Directors of the Company.
• Mr. Chetan Bipinchandra Shah is not related inter-se to any other Directors of the Company.
• Both are not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.

How to read this

The two senior leadership roles continue with the same individuals for a further three-year term each. The re-appointments carry into effect from October 15, 2026 and November 10, 2026 respectively, and both are subject to shareholders' approval through a postal ballot process.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev